Novartis ships cell-culture flu vaccines; WHO recommends trivalent flu vax strain switch for 2015;

> Novartis ($NVS) has shipped its cell-culture flu vaccines for the 2014-2015 season. Report

> The World Health Organization (WHO) recommends switching two of the three strains in 2015 trivalent vaccines. More

> The FDA has granted MabVax's neuroblastoma vaccine candidate its orphan drug designation. Release

> Dr. Jon Andrus will join the Sabin Vaccine Institute as EVP and director of vaccine advocacy and education. Release

And Finally... Novartis' vaccine facility in North Carolina is a possible second site to make experimental Ebola drug ZMapp. Report

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.